IleneWeitzMD

Hematology • Los Angeles, CA

Professor of Clinical Medicine, USC School of Medicine

Join to view full profile

Dr. Weitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weitz's full profile

Already have an account?

Office
1441 Eastlake Ave
Los Angeles, CA 90089
Phone+1 323-865-3105

Fax+1 213-861-5863

Education & Training

Cedars-Sinai Medical CenterResidency, Internal Medicine, 1976 - 1979
MCP-Hahnemann College of MedicineClass of 1976

Certifications & Licensure

CA State Medical License 1977 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012

Publications & Presentations

PubMed

3 citations
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.
David Dingli, Carlos De Castro Iii, Jamie Koprivnikar, Austin Kulasekararaj, Jaroslaw Maciejewski
Hematology. 2024-12-01
Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B.
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, Bernd Jilma
Eclinicalmedicine. 2024-08-01
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label exte...
Alexander Röth, Catherine M Broome, Wilma Barcellini, Bernd Jilma, Quentin A Hill
Eclinicalmedicine. 2024-08-01

Lectures

Aware of the Rare: Diagnosing and Treating Immune-Mediated Hematologic Disorders
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel MethodDecember 8th, 2020
Subcutaneous Formulations of Apellis’ Pegcetacoplan and Alexion’s Ultomiris in PNH Draw Doubt for Wide UtilitySeptember 16th, 2020
FDA Approves UltomirisDecember 21st, 2018